Finding 1: In collaboration with James Thaventhiran at Cambridge and Kaan Boztug in Austria, we identified two patients with recessive loss of function mutations in interleukin 6 receptor (IL6R) leading to absent Il-6 receptor signaling, severe atopic dermatitis, bacterial skin and lung infections, elevated immunoglobulin E (IgE) and markedly abnormal inflammatory responses. The findings were important for several reasons. First, they contextualized the role for IL-6 signaling in diseases of high IgE and infection, such as STAT3DN, gp130 deficiency and ZNF341 deficiency; they showed that IL6R is the likely binding partner for gp130 that is required to prevent elevated IgE. The second reason is that it demonstrates the potential consequences of IL-6R blockade, as is now commonly in use, highlighting the differences between inborn IL6R deletion and blockade later in life. The fact that most treated adults do not develop allergy (but can develop infection) suggests that IL6R signaling is necessary only early in life to prevent IgE elevation and severe dermatitis. The results were published in the Journal of Experimental Medicine. Finding 2: In collaboration with multiple groups throughout the world, we showed the experience of treated patients with STAT1 or STAT3GOF mutations with JAK inhibitors. We found that these inhibitors can be effective in the pathway specific treatment of these disorders, but that they tend to be more effective in combination with IL-6R blockade (mentioned in finding 1) and when initiated earlier in the disease course. The results were published in the Journal of Allergy and Clinical Immunology.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2019
Total Cost
Indirect Cost
City
State
Country
Zip Code
Valent, Peter; Akin, Cem; Bonadonna, Patrizia et al. (2018) Mast cell activation syndrome: Importance of consensus criteria and call for research. J Allergy Clin Immunol 142:1008-1010
Oh, Kyu-Seon; Gottschalk, Rachel A; Lounsbury, Nicolas W et al. (2018) Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression. J Immunol 201:757-771
Natarajan, Mukil; Hsu, Amy P; Weinreich, Michael A et al. (2018) Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency. J Allergy Clin Immunol 142:993-997.e3
Lyons, Jonathan J; Milner, Joshua D (2018) Primary atopic disorders. J Exp Med 215:1009-1022
Sabato, Vito; Chovanec, Jack; Faber, Margaretha et al. (2018) First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease. J Clin Immunol 38:457-459
Lyons, Jonathan J; Stotz, Stephanie C; Chovanec, Jack et al. (2018) A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number. Genet Med 20:503-512
Milner, Joshua D (2018) TCR Signaling Abnormalities in Human Th2-Associated Atopic Disease. Front Immunol 9:719
Schussler, Edith; Yang, Amy; Lyons, Jonathan J et al. (2018) Persistent tryptase elevation in a patient with Gaucher disease. J Allergy Clin Immunol Pract 6:697-699
Ma, Chi A; Xi, Liqiang; Cauff, Brian et al. (2017) Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea. Blood 129:650-653
Schwerd, Tobias; Twigg, Stephen R F; Aschenbrenner, Dominik et al. (2017) A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med 214:2547-2562

Showing the most recent 10 out of 54 publications